Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Global Health Innovative Technology Fund
AddedFeb 15, 2024
UpdatedJun 28, 2026
Global Health Innovative Technology Fund

Global Health Innovative Technology Fund

Tokyo-based nonprofit, Global Health Innovative Technology Fund, develops health technologies for Japan.

HQ
Tokyo, Tokyo, JP
Founded
2013
Overview
Compare
Employees

Global Health Innovative Technology Fund operates as a non-profit organization.

The Organization develops new health technologies which includes drugs, vaccines, and diagnostics. Global Health Innovative Technology Fund serves customers in Japan.

Similar Companies

Teamfund logo

Teamfund

teamfundhealth.org

Mitsubishi Electric Innovation Fund logo

Mitsubishi Electric Innovation Fund

Johnson & Johnson Impact Ventures logo

Johnson & Johnson Impact Ventures

Global health sciences venture fund logo

Global health sciences venture fund

GNI Group logo

GNI Group

gnipharma.com

West Health Investment Fund logo

West Health Investment Fund

Funding Global Innovation logo

Funding Global Innovation

J-Impact logo

J-Impact

j-impact.fund

EIT Health logo

EIT Health

eithealth.eu

Vitrix Health logo

Vitrix Health

Covid-19 Innovation Acceleration Fund. logo

Covid-19 Innovation Acceleration Fund.

Global Health Innovative Technology Fund - Quick Facts

Who are Global Health Innovative Technology Fund's competitors?

Companies similar to Global Health Innovative Technology Fund include Teamfund, Mitsubishi Electric Innovation Fund, Johnson & Johnson Impact Ventures and Global health sciences venture fund.

When was Global Health Innovative Technology Fund founded?

Global Health Innovative Technology Fund was founded in 2013.

Where is Global Health Innovative Technology Fund's headquarters located?

Global Health Innovative Technology Fund's headquarters is located in Tokyo, Tokyo, JP.

How many employees does Global Health Innovative Technology Fund have?

Global Health Innovative Technology Fund has 20 employees as of Feb 4, 2024.

Classification

Technology
  • Biotech
  • HealthTech
Geographic Exposure
  • Japan
Customer
  • Government
  • Non-Profit
Main Product
  • Health Technologies
NAICS
  • 621000Ambulatory Health Care Services
  • 621400Outpatient Care Centers
  • 621490Other Outpatient Care Centers
  • 621491HMO Medical Centers
  • 620000Health Care and Social Assistance
SIC
  • 8010Offices And Clinics Of Doctors Of Medicine
  • 8011Offices And Clinics Of Doctors Of Medicine
  • 8000Health Services
Show 10 more industry codes
NAICS
  • 610000Educational Services
  • 611300Colleges, Universities, and Professional Schools
  • 611310Colleges, Universities, and Professional Schools
  • 611000Educational Services
SIC
  • 8220Colleges, Universities, Professional Schools, And Junior Colleges
  • 8221Colleges, Universities, And Professional Schools
  • 8200Educational Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8290Schools And Educational Services, Not Elsewhere Classified
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified